Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
BRTX
$2.21
-1.34%
BRTX
· BioRestorative Therapies, Inc.
$2.21
-0.03 (-1.34%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“we believe we do not have sufficient cash for at least twelve months after the issuance date of the financial statements included in this Quarterly Report which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$2.97M
Shares
1.27M
Volume · Oct 6
79.66K
Avg daily vol (19 sessions)
31.78K
All webcasts
Earnings call · FY2024 Q4
BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$43,300
+124.4% YoY
Gross margin · derived Q4
92.3%
Net income · derived Q4
-$1.64M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 27, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 28, 2025 · complete as-filed document